Seamless phase II/III designs

Statistical Methods in Medical Research

Volumn 20, Issue 6, 2011, Pages 623-634

  Stallard, Nigel ^a   Todd, Susan ^b  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b UNIVERSITY OF READING   (United Kingdom)

Author keywords

adaptive design; interim analysis; sequential design; treatment selection

Indexed keywords

ARTICLE; DRUG MANUFACTURE; DRUG RESEARCH; MATHEMATICAL PARAMETERS; METHODOLOGY; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); STATISTICAL ANALYSIS; ADAPTIVE DUNNET METHOD; CALCULATION; DRUG DEVELOPMENT; HUMAN; INVERSE NORMAL METHOD; MATHEMATICAL COMPUTING; PROBABILITY; PROGRAM DEVELOPMENT; SEQUENTIAL ANALYSIS; STATISTICAL DISTRIBUTION; STUDY DESIGN;

CLINICAL TRIALS, PHASE II AS TOPIC; CLINICAL TRIALS, PHASE III AS TOPIC; DRUG DESIGN; RESEARCH DESIGN;

EID: 84555178552     PISSN: 09622802     EISSN: 14770334     Source Type: Journal    
DOI: 10.1177/0962280210379035     Document Type: Article

References (42)

1. Sheiner LB. Learning versus confirming in clinical drug development. Clinical Pharmacology and Therapeutics. 1997 ; 61: 275-91 (Pubitemid 27145429)
2. Bretz F, Schmidli S, König F, Racine A, Maurer W. Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim: general concepts. Biometrical Journal. 2006 ; 48: 623-34 (Pubitemid 44367905)
3. Schmidli H, Bretx F, Racine A, Maurer W. Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim: applications and practical considerations. Biometrical Journal. 2006 ; 48: 635-43 (Pubitemid 44367906)
4. Gallo P, Chuang-Stein C, Dragalin V, Gaydos B, Krams M, Pinheiro J. Adaptive designs in clinical drug development: an executive summary of the PhRMA Working Group. Journal of Biopharmaceutical Statistics. 2006 ; 16: 275-83
5. Maca J, Bhattacharya S, Dragalin V, Gallo P, Krams M. Adaptive seamless Phase II/III designs: background, operational aspects, and examples. Drug Information Journal. 2006 ; 40: 463-73 (Pubitemid 44721124)
6. Stallard N, Todd S. Sequential designs for phase III clinical trials incorporating treatment selection. Statistics in Medicine. 2003 ; 22: 689-703 (Pubitemid 36266961)
7. Bauer P, Kieser M. Combining different phases in the development of medical treatments within a single trial. Statistics in Medicine. 1999 ; 18: 1833-48 (Pubitemid 29364054)
8. Koenig F, Brannath W, Bretz F, Posch M. Adaptive Dunnett tests for treatment selection. Statistics in Medicine. 2008 ; 27: 1612-25 (Pubitemid 351566086)
9. Jennison C, Turnbull BW. Group-sequential analysis incorporating covariate information. Journal of the American Statistical Association. 1987 ; 92: 1330-41
10. Hochberg Y, Tamhane A. Multiple comparison methods. Statistics in Medicine. 2001 ; 20: 3861-73
11. Marcus R, Peritz E, Gabriel KR. On closed testing procedures with special reference to ordered analysis of variance. Biometrika. 1976 ; 63: 655-60
12. Dunnett CW. A multiple comparison procedure for comparing several treatments with a control. Journal of the American Statistical Association. 1955 ; 50: 1096-121
13. Kelly PJ, Sooriyarachchi MR, Stallard N, Todd S. A practical comparison of group-sequential and adaptive designs. Journal of Biopharmaceutical Statistics. 2005 ; 15: 719-38 (Pubitemid 40967311)
14. Müller H-H, Schäfer H. Adaptive group sequential designs for clinical trials: combining the advantages of the adaptive and of classical group sequential approaches. Biometrics. 2001 ; 57: 886-91 (Pubitemid 32801186)
15. Whitehead J The design and analysis of sequential clinical trials. Chichester: Wiley ; 1997 :
16. Jennison C, Turnbull BW Group sequential methods with applications to clinical trials. London: Chapman & Hall ; 2000 :
17. Lan KKG, DeMets DL. Discrete sequential boundaries for clinical trials. Biometrika. 1983 ; 70: 659-63
18. Kim K, DeMets DL. Design and analysis of group sequential tests based on the type I error spending rate function. Biometrika. 1987 ; 74: 149-54
19. Stallard N, Facey KM. Comparison of the spending function method and the Christmas tree correction for group sequential trials. Journal of Biopharmaceutical Statistics. 1990 ; 6: 361-73
20. Armitage P, McPherson CK, Rowe BC. Repeated significance tests on accumulating data. Journal of the Royal Statistical Society, Series A. 1969 ; 132: 235-44
21. Jennison C Computing Science and Statistics: Proceedings of the 25th Symposium on the Interface. Tartar ME Lock MD, ed. California: Interface Foundation of America ; 1993: 253-72.
22. Bauer P, Köhne K. Evaluation of experiments with adaptive interim analyses. Biometrics. 1994 ; 51: 1315-24
23. Lehmacher W, Wassmer G. Adaptive sample size calculations in group sequential tests. Biometrics. 1999 ; 55: 1286-90
24. Brannath W, Posch M, Bauer P. Recursive Combination Tests. Journal of the American Statistical Association. 2002 ; 97: 236-44
25. Müller H-H, Schäfer H. A general statistical principle for changing a design any time during the course of a trial. Statistics in Medicine. 2004 ; 23: 2497-508 (Pubitemid 39149263)
26. Thall PF, Simon R, Ellenberg SS. A two-stage design for choosing among several experimental treatments and a control in clinical trials. Biometrics. 1988 ; 45: 537-47 (Pubitemid 19165264)
27. Thall PF, Simon R, Ellenberg SS. Two-stage selection and testing designs for comparative clinical trials. Biometrika. 1989 ; 75: 303-10
28. Schaid DJ, Wieand S, Therneau TM. Optimal two-stage screening designs for survival comparisons. Biometrika. 1990 ; 77: 507-13
29. Jennison C, Turnbull BW. Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim: opportunities and limitations. Biometrical Journal. 2006 ; 48: 650-55 (Pubitemid 44367908)
30. Stallard N, Friede T. Flexible group-sequential designs for clinical trials with treatment selection. Statistics in Medicine. 2008 ; 27: 6209-27
31. Posch M, Koenig F, Branson M, Brannath W, Dunger-Baldauf C, Bauer P. Testing and estimation in flexible group sequential designs with adaptive treatment selection. Statistics in Medicine. 2005 ; 24: 3697-714 (Pubitemid 43115726)
32. Jennison C, Turnbull BW. Repeated confidence intervals for group sequential trials. Controlled Clinical Trials. 1984 ; 5: 33-45 (Pubitemid 14149644)
33. Jennison C, Turnbull BW. Interim analyses: the repeated confidence interval approach. Journal of the Royal Statistical Society, Series B. 1989 ; 51: 305-61
34. Todd S, Stallard N. A new clinical trial design combining phases II and III: Sequential designs with treatment selection and a change of endpoint. Drug Information Journal. 2005 ; 39: 109-18 (Pubitemid 40647117)
35. Friede T, Stallard N. A comparison of methods for adaptive treatment selection. Biometrical Journal. 2008 ; 50: 767-81
36. Burman C-F, Sonesson C. Are flexible designs sound?. Biometrics. 2006 ; 62: 664-9
37. Bauer P, Posch M. Letter to the editor: modification of the sample size and the schedule of interim analyses in survival trials based on data inspections. Statistics in Medicine. 2004 ; 23: 1333-35 (Pubitemid 38514827)
38. Stallard N. A confirmatory seamless phase II/III clinical trial design incorporating short-term endpoint information. Statistics in Medicine. 2010 ; 29: 959-971
39. Stallard N, Todd S, Whitehead J. Estimation following selection of the largest of two normal means. Journal of Statistical Planning and Inference. 2008 ; 135: 402-19
40. Bauer P, Koenig F, Brannath W, Posch M. Selection and bias-two hostile brothers. Statistics in Medicine. 2009 ; 29: 1-13
41. Shen L. An improved method of evaluating drug effect in a multiple dose clinical trial. Statistics in Medicine. 2001 ; 20: 1913-29 (Pubitemid 32605721)
42. Stallard N, Todd S. Point estimates and confidence regions for sequential trials involving selection. Journal of Statistical Planning and Inference. 2005 ; 135: 402-19 (Pubitemid 41235780)